| 中文别名 |
替莫唑胺;8-氨基甲酰基-3-甲基咪唑[5,1-d]并-1,2,3,5-四氮嗪-4-(3H)-酮;替目唑胺;Temozolomide 替莫唑胺;非洛地平;替莫唑胺 USP标准品;替莫唑胺Temozolomid;替莫唑胺重氮盐;3,4-二氢-3-甲基-4-氧代咪唑并[5,1-d]-1,2,3,5-四嗪-8-甲酰胺;3-甲基-4-氧代-8-咪唑并[5,1-d][1,2,3,5]四嗪甲酰胺;4-甲基-5-氧代-2,3,4,6,8-五氮杂双环[4.3.0]壬-2,7,9-三烯-9-甲酰胺;4-甲基-5-氧代-2,3,4,6,8-五氮杂双环[4.3.0]壬基-2,7,9-三烯-9-甲酰胺;8-氨基甲酰基-3-甲基-3-甲基咪唑[5,1-d]并-1,2,3,5-四氮嗪-4（3H）-酮;8-氨甲酰-3-甲基咪唑[5,1-d]-1,2,3,5-四嗪-4(3H)-酮;替莫唑胺(对照品) |
| 英文别名 |
3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;4-Methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide;Temozolomide;3-Methyl-4-oxo-3,4-dihydroimidazo-[5,1-d][1,2,3,5]tetrazine-8-carboxamide;Temozolamide;Temozolomid;CCRG 81045;NSC 362856;temodar;TEMODAR TEMOZOLOMIDE;temosolomide;TZM;3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide;3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;Methazolastone;Temodal;Temozolomidum [Latin];Temozolodida [Spanish];Temozolomidum;Sch 52365;MB 39831;M&B 39831;8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one;M & B 39831;3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide;3-Methyl-;TMZ;3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide (ACI);3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide;3-Methyl-4-oxo-3H,4H-imidazo[4,3-d][1,2,3,5]tetrazine-8-carboxamide;3-Methyl-4-oxo-8-imidazolo[5,1-d][1,2,3,5]tetrazinecarboxamide;3-Methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;3-Methyl-8-carbamoylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one;8-Carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one;M and B 39831;T 2577;Temomedac;BCP03692;Q425088;Temozolomide 100 microg/mL in Acetonitrile;Temozolomide (JP18/USAN/INN);Temozolomide [USAN:INN:BAN];TEMOZOLOMIDE [VANDF];AB00639915_11;Temozolomide, United States Pharmacopeia (USP) Reference Standard;Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-;NCGC00167429-01;TEMOZOLOMIDE [WHO-DD];UNII-YF1K15M17Y;HMS3372K13;Mk-7365;DL-190;Temozolodida;BP-25388;Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-;Temodal (TN);ALBB-021358;IMIDAZO(5,1-D)-1,2,3,5-TETRAZINE-8-CARBOXAMIDE, 3,4-DIHYDRO-3-METHYL-4-OXO-;Tox21_112433;BDBM50034562;BIDD:GT0204;BCP0726000154;Z1201620684;3-methyl-4-oxo-8-imidazo[5,1-d][1,2,3,5]tetrazinecarboxamide;CHEBI:72564;Q-201786;TEMOZOLOMIDE [EP MONOGRAPH];C6H6N6O2;AC-758;HMS2051O12;SW197500-4;TEMOZOLOMIDE [USAN];Pharmakon1600-01502289;CCG-100870;3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide;KS-1216;3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide (Temozolomide);CHEMBL810;Temodar (TN);BRN 5547136;temozolomida;Temozolomide, VETRANAL(TM), analytical standard;BRD-K32107296-001-16-9;NSC-362856;BRD-K32107296-001-04-5;BT164447;NSC362856;NSC-759883;TEMOZOLOMIDE [USP MONOGRAPH];NCGC00167429-04;TEMOZOLOMIDE [INN];SR-01000759347-5;YF1K15M17Y;D06067;3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide;Temozolomide, >=98% (HPLC);3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide;Sch-52365;HMS3269P05;Temozolomide, Pharmaceutical Secondary Standard; Certified Reference Material;3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-ca... |
